Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 12692
Country/Region: Haiti
Year: 2016
Main Partner: Ministre de la Sante Publique et Population - Haiti
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $15,435,752 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,376,515
Care: Orphans and Vulnerable Children (HKID) $1,293,766
Care: TB/HIV (HVTB) $548,950
Care: Pediatric Care and Support (PDCS) $735,928
Laboratory Infrastructure (HLAB) $1,860,000
Strategic Information (HVSI) $1,198,188
Health Systems Strengthening (OHSS) $800,000
Testing: HIV Testing and Counseling (HVCT) $1,109,343
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,078,510
Treatment: Adult Treatment (HTXS) $4,860,339
Treatment: Pediatric Treatment (PDTX) $574,213
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 771
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 84
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 781
GEND_GBV Number of people receiving post-GBV care 2017 865
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 12,984
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 12,984
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 143,114
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 103,636
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 272,718
HTS_TST Service Delivery Point (Facility): Inpatient 2017 2,257
HTS_TST Service Delivery Point (Facility): Pediatric 2017 25,961
HTS_TST Service Delivery Point (Facility): PMTCT 2017 76,951
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,097
HTS_TST Service Delivery Point (Facility): VCT 2017 165,452
HTS_TST Sum of Aggregated Age/Sex <15 2017 25,968
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 246,750
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 272,718
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 205
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 205
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 3,773
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,726
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 6,066
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 5,598
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 11,664
PMTCT_ART Already on ART at beginning of current pregnancy 2017 563
PMTCT_ART New on ART 2017 813
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 76,947
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 753
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 612
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 26
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 33
PMTCT_EID Sum of Infant Age disaggregates 2017 1,365
PMTCT_STAT By: Known positives at entry 2017 658
PMTCT_STAT By: Number of new positives identified 2017 792
PMTCT_STAT Number of new ANC and L&D clients 2017 78,819
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 76,947
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,450
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 6
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 148
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 102
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 258
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 258
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 493
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 148
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 493
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 74
TB_SCREENDX Screen Result: Screened Positive for TB 2017 493
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 13,074
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 8,715
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 624
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 414
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 22,830
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 60
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,201
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 37
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 801
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 2,099
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,298
TX_CURR Aggregated Age/Sex: <15 Female 2017 627
TX_CURR Aggregated Age/Sex: <15 Male 2017 414
TX_CURR Aggregated Age/Sex: 15+ Female 2017 13,074
TX_CURR Aggregated Age/Sex: 15+ Male 2017 8,715
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 22,830
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,041
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 21,789
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 22,830
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 164
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 164
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 3,815
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 2,762
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 6,905
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 6,905
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 22,830
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 17,123
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 469
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 309
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 9,805
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 6,540
TX_PVLS Numerator: Indication: Routine 2017 15,409
TX_PVLS Numerator: Indication: Targeted 2017 1,714
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 627
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 414
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 13,074
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 8,715
TX_PVLS_den Denominator: Indication: Routine 2017 20,548
TX_PVLS_den Denominator: Indication: Targeted 2017 2,282
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 128
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 89
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,553
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,485
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 4,255
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 5,452
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 164
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 110
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,270
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,908
Cross Cutting Budget Categories and Known Amounts Total: $7,650,000
Human Resources for Health $7,350,000
Key Populations: MSM and TG $50,000
Training of health workers and community outreach workers
Collection and use of strategic information
Key Populations: Sex Workers $50,000
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Gender: Gender Based Violence (GBV) $50,000
Post GBV Care
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $50,000
Equity in HIV prevention, care, treatment and support
Implementation
Capacity building
Monitoring and Evaluation
Motor Vehicles: Purchased $100,000